Researchers in UGA Vet School discover a mechanism that blocks replication of a retrovirus

July 19, 2004

A team of scientists led by University of Georgia researchers has discovered a naturally occurring mechanism that blocks a critical step late in retrovirus replication. In the long term, the results could lead to the design of new therapeutic strategies or drugs against retroviruses, which cause diseases such as AIDS and certain leukemias.

Studying a transmissible lung cancer of sheep, the researchers found that the mechanism stops cancer-causing retroviruses from exiting host cells and spreading. Their findings shed new light on how retroviruses evolved and will help explain late steps in the retroviral life cycle.

The findings were published today in the Proceedings of the National Academy of Sciences. The team was led by Massimo Palmarini, a virologist at UGA's College of Veterinary Medicine. Co-authors are Manuela Mura, Pablo Murcia and Marco Caporale of UGA; Thomas Spencer of Texas A&M University; and Kunio Nagashima and Alan Rein of the HIV Drug Resistance Program, National Cancer Institute in Frederick, Md.

This particular sheep lung cancer - called ovine pulmonary adenocarcinoma - led to the death of Dolly, the first cloned mammal. It is a chronic problem for the sheep industry in Europe and the United Kingdom.

"The cancer is caused by a retrovirus that passes from sheep to sheep like any other virus, such as the flu," Palmarini said.

Like all viruses, retroviruses insert their genetic material into host cells and then force the host to make copies of the virus. Unlike other viruses, however, retroviruses permanently insert a copy of their genes into the genome of cells they invade.

During evolution, some retroviruses infected host germlines, underwent small changes that allowed the "alien" DNA to reside in the host genome permanently and be inherited by offspring. These so-called "endogenous retroviruses" are usually harmless and cannot orchestrate production of infective virus particles.

"Every sheep on the planet has endogenous retroviruses that are present in the genome like every other gene," Palmarini said. "In fact, all animal species - humans included - have endogenous retroviruses."

Sheep have some 20 different endogenous retroviruses related to the lung cancer-causing Jaagsiekte sheep retrovirus or JSRV.

Scientists believe that some endogenous retroviruses protect hosts by interfering with the infection by related disease-causing retroviruses.

Palmarini's team discovered an endogenous retrovirus called enJS56A1 that makes viral particles that cannot escape from the cell. It also interferes with the cancer-causing retrovirus JSRV's ability to exit host cells. The blocked escape route is attributed mainly to a single amino acid substitution in a protein that comprises the virus's protective shell.

Other scientists have reported endogenous retroviruses that interfere with infective retrovirus replication at different points in early states of the cycle - specifically by blocking entry to the host cell or blocking before insertion of viral DNA into the host genome. This is the first report of an endogenous retrovirus interfering with the viral replication so late in the cycle.

Understanding how enJS56A1 functions could provide a model for designing new anti-retroviral therapies that work on cells already infected by retroviruses. Some common anti-retroviral drugs, such as reverse transcriptase inhibitors, function only immediately after the virus infects a new cell.
-end-
This research was funded by grants from the Georgia Cancer Coalition and the National Institutes of Health National Cancer Institute.

University of Georgia

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.